Anita Gulati

Anita Gulati

Auto-generated profile, based on publicly available information

Anita Gulati

Department of Zoology, DeenDayal Upadhyaya College, University of Delhi, Delhi, 110078, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
DBDhitri Borah
Dhitri Borah
SHSibasree Hojaisa
Sibasree Hojaisa
ISIndira Sarma
Indira Sarma
AMAnil Kumar Mavi
Anil Kumar Mavi
TSTEJVEER SINGH
TEJVEER SINGH
SMSaurabh Maru
Saurabh Maru
Cancer is a leading cause of death around the world. Cancer is still a complex disease over the years that needs to be cured. Traditional cytotoxic approaches, which have been used for years to treat neoplastic diseases, are limited due to the intricacy and low efficiency of cancer cells. Researchers are consequently pushed to seek more potent therapeutic strategies. Chimeric antigen receptor (CAR-T) cell therapy is one such innovative approach in which T lymphocytes are genetically engineered to target cancer cells. Despite the outstanding accomplishment in patients with haematological malignancies, CAR-T cell treatment has demonstrated minimal impact on solid tumors due to a number of obstacles, including proliferation, stability, trafficking, and fate within tumors. Furthermore, interactions between the host and tumour microenvironment with CAR-T cells significantly alter CAR-T cell activities. Designing and implementing these treatments additionally also requires a complex workforce. Overcoming these significant challenges, there is a requirement for innovative strategies for developing CAR-T cells with greater anti-tumor efficacy and reduced toxicity. In this review article, the current advancement in CAR-T cell technology in order to increase clinical efficacy in both solid and hematological tumors, as well as potential solutions to overcome the limitations of CAR-T cell therapy in both solid and haematological tumors.

5 July 2022 in arXiv
Verified
Preprint
Open access
PDF file
RSRenu Solanki
Renu Solanki
MKMonisha Khanna
Monisha Khanna
SAShailly Anand
Shailly Anand
AGAnita Gulati
Anita Gulati
PKPrateek Kumar
Prateek Kumar
DKDushyant Kumar
Dushyant Kumar
Agent based modelling is a computational approach that aims to understand the behaviour of complex systems through simplified interactions of programmable objects in computer memory called agents. Agent based models (ABMs) are predominantly used in fields of biology, ecology, social sciences and economics where the systems of interest often consist of several interacting entities. In this work, we present a Julia package EasyABM.jl for simplifying the process of studying agent based models. EasyABM.jl provides an intuitive and easy to understand functional approach for building and analysing agent based models.